ObsEva SA (OBSEF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 20, 2026
ObsEva Revenue
ObsEva had revenue of $19.64M in the twelve months ending June 30, 2023, down -11.55% year-over-year. In the year 2022, ObsEva had annual revenue of $19.64M, down -11.55%.
Revenue
19.64M
Revenue Growth
-11.55%
P/S Ratio
0.00
Revenue / Employee
1.31M
Employees
15
Market Cap
11.72K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 19.64M | -2.56M | -11.55% |
| Dec 31, 2021 | 22.20M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aridis Pharmaceuticals | 22.36M |
| Gelesis Holdings | 12.14M |
| GeneLink | 1.58M |
| Trevena | 546.00K |
| Entia Biosciences | 265.47K |